Ultragreen Ai Ltd (SGX:ULG) Share Price

Company Profile

Business description
Ultragreen Ai Ltd is engaged in the sales of Indocyanine Green (ICG) pharmaceutical products and cardiology Picture Archiving and Communication System (PACS) software and associated products and services. It provides a fluorescence imaging ecosystem designed to support surgeons with real-time perfusion data and visualization capabilities. The company is organised into business units based on its products and services and operates in (a) the Diagnostic Green (DxG) - Americas segment; (b) the DxG - Rest of the World segment; and (c) the UltraLinQ segment. The company generates the maximum of its revenue from the the DxG - Rest of the World segment, which focuses on the sales of ICG vials and related pharmaceutical products.
Contact
463 MacPherson Road
M463
Singapore368181
SGP
T: +65 98172903
https://www.ultragreen.ai
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
101

Recommended

Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.

Mark Taylor | 04 August 2026

Pricing strength outweighs temporary production headwinds.

Mark Taylor | 03 August 2026

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.

Seth Goldstein, CFA | 02 August 2026

Index	Last price	Change	% Change
All Ordinaries	9,178.40	69.70	0.77%
CAC 40	8,613.82	104.18	1.22%
DAX 40	26,001.31	372.07	1.45%
Dow JONES (US)	53,178.41	693.38	1.32%
FTSE 100	10,857.70	10.35	-0.10%
HKSE	26,009.40	124.97	0.48%
NASDAQ	25,913.90	540.04	2.13%
Nikkei 225	63,754.90	607.12	-0.94%
NZX 50 Index	13,813.13	38.20	0.28%
S&P 500	7,600.50	110.78	1.48%
S&P/ASX 200	9,019.30	70.30	0.79%
SSE Composite Index	3,809.66	22.60	-0.59%